| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
SVP, Clinical Dev, Drug Safety
1 company
Kouchakji Elias is a SVP, Clinical Dev, Drug Safety at FIBROGEN INC. Recent SEC Form 4 filings include 0 buys and 1 sell.
Estimated insider holdings value: $1.0M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 28, 2019 | KYNB Fibrogen Inc | SVP, Clinical Dev, Drug Safety | Sell | 2,873 | $45.00 | $129,285.00 | -2.6% |